First FDA Approved Sleep Apnea Medication
The FDA approved tirzepatide, a sleep apnea medication known as Zepbound for managing adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. According to the Director of the Division of Pulmonology, Allergy, and Critical Care in the FDA’s Center, Sally Seymour, MD said in a statement, “Today’s approval marks the first drug treatment option for […]
